• Carvedilol Phosphate for Reproducible Cell Assays

  2026-08-17

  Learn how Carvedilol Phosphate, SKU C6404, can support better-controlled viability, proliferation, and GPCR-signaling experiments. This scenario-driven guide covers solvent selection, assay controls, ischemia–reperfusion interpretation, and practical supplier evaluation.

• Berberine Hydrochloride: AMPK Research Workflows

  2026-08-17

  Build reproducible Berberine hydrochloride experiments around AMPK signaling, LDLR expression, lipid metabolism, and cancer-cell stress responses. This workflow also translates mitochondrial assay logic from a cardiotoxicity study into practical controls without overstating evidence across models.

• Annexin V-Cy5 Apoptosis Kit: 5 Lab Scenarios

  2026-08-16

  This scenario-based guide explains how Annexin V-Cy5 Apoptosis Kit SKU K2005 supports rapid phosphatidylserine-based apoptosis assessment in microscopy and flow cytometry. It also shows how to distinguish cell death from lysosomal stress, optimize handling, and select a practical fluorescent assay for biomedical and cancer research.

• Capsaicin: TRPV1 and KDM1A Research Workflows

  2026-08-15

  Capsaicin is a versatile research tool for separating TRPV1-driven sensory responses from KDM1A-dependent cancer phenotypes. This workflow-focused guide covers dose selection, calcium assays, gastric cancer studies, chronic dermatitis models, and troubleshooting for reproducible translational experiments.

• Streptavidin Magnetic Beads for HBV Entry Assays

  2026-08-14

  Discover how streptavidin magnetic beads can turn the CDC42–NTCP–macropinocytosis model of HBV entry into more discriminating capture assays. This guide combines mechanistic virology, low-background bead chemistry, and practical workflow design for biotinylated targets.

• Maternal IL-17A Predicts Neonatal GBS Risk

  2026-08-14

  A prospective Moroccan mother–newborn study found that reduced maternal IL-17A, IL-1β, and IL-4 responses among GBS-colonized women were associated with invasive neonatal disease. The work positions circulating maternal IL-17A as a potential risk-stratification biomarker and links clinical outcomes with ex vivo TLR1/2 and TLR4 stimulation data.

• EdU Flow Cytometry Assay Kits (Cy3) Workflow

  2026-08-13

  EdU Flow Cytometry Assay Kits (Cy3) convert a short DNA-synthesis pulse into a quantitative flow-cytometry readout without harsh DNA denaturation. This workflow guide shows how to apply the assay to LUAD drug studies, cell-cycle profiling, genotoxicity testing, and multiplexed biomarker experiments while controlling the variables that most often compromise reproducibility.

• MK 0893: Glucagon Receptor Antagonist Workflows

  2026-08-13

  MK 0893 enables nanomolar interrogation of GCGR binding, cAMP signaling, and glucagon-driven glucose regulation. This practical guide connects receptor pharmacology with cell-based, selectivity, and in vivo workflows while highlighting controls that improve assay reproducibility.

• Methoxy-X04 Workflows for Amyloid Imaging

  2026-08-12

  Methoxy-X04 converts amyloid pathology into an actionable fluorescent readout for tissue, vascular, and in vivo Alzheimer's disease research. This workflow-focused guide shows how to pair plaque imaging with microglial and extracellular-vesicle experiments, while separating genuine biological changes from probe, timing, and optical artifacts.

• Sitagliptin phosphate monohydrate Workflows

  2026-08-12

  Sitagliptin phosphate monohydrate provides a practical DPP-4 inhibition tool for separating endogenous incretin effects from intestinal mechanosensation. This workflow connects biochemical potency, GLP-1 and GIP measurements, oral glucose tolerance, and obesity-related satiety phenotypes without assuming that every metabolic response is GLP-1 dependent.

• Neurotensin: Designing Better NTR1 Assays

  2026-08-11

  Neurotensin is a versatile Neurotensin receptor 1 activator for connecting GPCR signaling with receptor trafficking and miR-133α modulation. This assay-design guide adds a critical spectral-quality framework, showing how interference controls and analytical preprocessing can strengthen gastrointestinal cell studies.

• (-)-Blebbistatin in Cardiac Opto-Mechanics

  2026-08-11

  (-)-Blebbistatin is a selective non-muscle myosin II inhibitor for separating cytoskeletal mechanics from cardiac electrical behavior. This guide shows how to combine its reversible actomyosin perturbation with panoramic opto-electrical mapping to design more interpretable cardiac and cell-mechanics assays.

• PD0325901: MEK Inhibition in Cancer Research

  2026-08-10

  PD0325901 is a selective MEK inhibitor that reduces phosphorylated ERK and suppresses tumor growth in selected mouse xenograft models. Its research value includes pathway interrogation, cell-cycle analysis, apoptosis induction in cancer cells, and comparison of MEK-dependent phenotypes with emerging TERT-regulation biology.

• Topological Stress and Persistent rDNA Lesions

  2026-08-09

  Urbancokova, Hornofova and colleagues show that persistent ribosomal DNA damage, rather than genotoxic stress in general, is a central trigger for PML-nucleolar associations (PNAs). By combining chemical stressors with locus-specific I-PpoI cleavage and DNA-repair perturbations, the study connects topoisomerase or RNA polymerase I inhibition to rDNA lesion persistence, incomplete homologous recombination, and cellular senescence.

• CD38 CAR Binder Structures and Affinity Tuning

  2026-08-08

  This iScience study resolves how two CD38-targeting CAR binders, RP02 and 028, engage distinct structural regions and influence enzymatic function. Its structure-guided analysis shows that the attenuated 028R103G variant can reduce CAR-T fratricide while preserving antitumor cytotoxicity, offering a framework for balancing affinity, antigen selectivity, and functional safety.

15267 records 1/1018 page Next 12345 下5页 Last page